High-affinity transport of the branched-chain amino acids in Escherichia coli is mediated by two periplasmic binding protein-dependent transport systems (4, 25) . One of these systems, designated leucine specific (LS), contains a periplasmic binding protein, the livK gene product, which binds both isomers of leucine. The second system is a general system, designated LIV-I, and utilizes the leucineisoleucine-valine (LIV) binding protein, the livJ gene product. Genetic analysis has indicated that both high-affinity transport systems require at least two additional components, the products of the livH and livG genes (4, 24, 29) . All four genes, livJ, livK, livH, and livG, are clustered at minute 76 on the E. coli linkage map. By using recombinant DNA techniques, this cluster of genes has been cloned, and the exact location of the livJ and livK genes on plasmid pOX1 has been reported (20, 28) . The products of these genes, the LIV and LS binding proteins, have been extensively characterized (20) . Recently, the physical location of the livG gene on plasmid pOX1 and the identification of a new gene, livM, most likely involved in transport, have been reported (24) .
Although several binding protein-dependent transport systems have been studied in bacteria, the molecular basis of the transport process is not yet well understood (1, 3, 18, 19) . It is known, however, that these systems utilize both periplasmic binding proteins and membrane-associated components. Most binding protein-dependent transport systems derive their energy from either high-energy chemical bonds or a membrane potential (2, 15, 16) .
In this report, the location of the livH gene carried by pOX1 has been defined by transposon Tn5-mediated mutagenesis and genetic complementation studies with pOX1 derivative plasmids. We Corp. [cx-35SJdATP, the M13 universal primer, and Klenow polymerase were from New England Nuclear Corp. Acrylamide and N,N'-bismethyleneacrylamide were from Bio-Rad Laboratories. Agarose was from Bethesda Research Laboratories. Nonradioactive dideoxy-and deoxynucleotides were purchased from Pharmacia and P-L Biochemicals, Inc. Antibiotics and other chemicals were from Sigma Chemical Co. In most of the experiments, cells were grown in Lufia broth medium supplemented with 50 jig of thymine per ml. For the transport assays and for osmotic shock treatment, cells were grown in Vogel-Bonner medium (35) or MOPS (morpholinopropanesulfonic acid) minimal medium (26) supplemented with the appropriate amino acids (4) . Where appropriate, antibiotics were used at the following concentrations: ampicillin, 25 jig/ml; chloramphenicol, 20 i.g/ml; kanamycin, 25 p.g per ml; and tetracycline, 15 ,ug/ml. DNA manipulations. Restriction endonuclease digestions of plasmid DNA were performed as suggested by the suppliers. DNA ligations and transformations were performed as described previously (22) . Plasmid DNA was prepared from a mid-log-phase bacterial culture grown in rich medium by the sodium dodecyl sulfate (SDS) lysis procedure (22) . Plasmid DNA was further purified by dye-buoyant density centrifugation in an ethidium bromide-cesium chloride gradient as described previously (22) . Rapid preparations of 566 NAZOS ET AL. plasmid DNA from small volumes of cultures or from large size colonies were obtained by alkaline lysis and by the boiling method described previously (22) . The plasmid DNA and DNA fragments were analyzed by gel electrophoresis in 1 or 2% horizontal agarose slab gels in Tris acetate buffer or in 5% vertical acrylamide gels in Tris borate buffer (22) . Transposon insertion mutagenesis. Transposon insertions with the transposon TnS were introduced into the Tetr plasmid pOX1 by infection of strain W3110(pOX1) with phage Xc1857 b221 carrying the transposable element TnS (X:: TnS) as described previously (7). A 5-ml culture of strain W3110 containing pOX1, growing exponentially in Luria broth containing 0.2% maltose, was collected by centrifugation, suspended in 10 mM MgSO4, and mixed with A:: TnS at a multiplicity of infection of 5 to 10. The mixture was incubated at 30°C for 1 h. The cells were placed on fresh plates containing kanamycin and tetracycline to select for pOX1:: TnS transformants, and were incubated 48 h at 30°C. Sodium pyrophosphate was added to prevent phage readsorption. The kanamycin-and tetracycline-resistant colonies were collected by washing the cells off the plates with a small volume of Luria broth, and the plasmid DNA was isolated by a quick-screening method (30) . This plasmid DNA was used to transform the double transport mutant strain AE205 (livJ livH) to Kanr and Tetr. The kanamycinresistant, tetracycline-resistant colonies were then isolated on minimal media plates containing valine (0.05 mg/ml) to select for valine-resistant colonies, some of which might be LIV-I mutants. Thirty Valr transformants were isolated and screened for the presence of high-affinity L-valine and Lleucine transport and for the presence of the LIV binding protein.
Transport assays and detection of binding protein. Transport assays were performed on logarithmically growing cells in Vogel-Bonner or MOPS minimal medium as described previously (4) . Binding protein was detected in shock fluid as described previously (4) . DNA Plasmid DNA expression in minicells. Minicells were purified from the E. coli X1411 minicell-producing strain as described previously (9) with minor modifications. Transformed minicell-producing strains were grown to an A6No of 0.8 in 250 ml of MOPS-rich medium without leucine and containing the appropriate antibiotics to maintain the plasmids. Cells were harvested by centrifugation at 10,000 x g for 15 min at 4°C and suspended in 35 ml of BSGE buffer (150 mM NaCl, 5 mM KH2PO4, 5 mM Na2HPO4, 1 mM EDTA, 100 mg of gelatin per ml; pH 7.8). Parental cells were partially removed by centrifugation at 3,000 x g for 1 min. The supernatant fluid containing the partially purified minicells was centrifuged at 10,000 x g for 15 min to pellet the minicells. The contaminating viable cells were removed by using two cycles of centrifugation (Sorvall SW28 rotor at 5,000 rpm for 5 to 10 min) on a 5 to 30% sucrose gradient in BSGE buffer. Before the labeling step, minicells were incubated for 20 min at 37°C in MOPS-rich medium without leucine and methionine, to allow the decay of mRNA (28), and then labeled for 30 to 50 min by addition of 10 ,uCi of L-[35S]methionine per 0.1 ml. Labeled minicells were subjected to SDS-acrylamide gel electrophoresis as described previously (17) .
RESULTS
Location of livH gene in the liv regulon. We have previously reported the cloning of the E. coli high-affinity branchedchain amino acid transport regulon contained on a 13 kilobase (kb) EcoRI DNA fragment in plasmid pOX1 (27) . The precise locations of the livJ and livK transport genes on this plasmid have been determined by genetic complementation by using various cloned restriction fragments and DNA sequencing analysis (20) (Fig. 1) .
To identify the location of the livH gene in the liv region, we performed insertion inactivation mapping on the plasmid pOX1. E. coli W3110(pOX1) was infected with a temperature-sensitive :: TnS phage, and the kanamycin-and tetracycline-resistant colonies were isolated as described in Materials and Methods. These conditions provided a selection for random TnS insertions either in the chromosome or in plasmid pOX1 since Tetr selects for pOX1 and Kanr selects To confirm these results, we measured the high-affinity L-leucine transport activities of these transformants. Strain AE205(pOX1:: Tn5) transformants with a defective livJ gene would be expected to show a normal L-leucine transport activity due to the presence of the high-affinity leucinespecific transport system (4), while AE205(pOX1:: Tn5) transformants with a defective livH gene would be expected to have very low L-leucine transport activity since the livH gene is a common component for both of the high-affinity transport systems (4, 29) . By using these screening methods, we identified both livJ:: TnS and livH:: Tn5 insertions on pOX1. Complementation analysis of representative insertions is described in Table 2 . Transformed strain AE205-8 showed no high-affinity uptake for L-valine or L-leucine, suggesting that TnS had inactivated livH, whereas transformed strain AE205-24 showed high-affinity uptake for L-leucine only, indicating that TnS had inactivated the livJ gene (Fig. 1) . The complementing activity of pOX1 livH:: TnS and pOX1 livJ:: TnS derivative plasmids was verified by transforming strains AE404 and AE405, livH and livG mutants, respectively, and by measuring L-leucine transport (Table 2 ). In addition, the synthesis of the LIV binding protein of the AE205 pOX1:: TnS-transformed strains was examined. Strain AE205-8 expressed both the LIV and LS binding proteins, whereas strain AE205-24 synthesized only the LS binding protein (data not shown).
The location of the Tn5 insertion in the livH gene was determined by restriction mapping analysis, taking advantage of the known restriction cleavage sites in plasmid pOX1 and in transposon TnS (27, 31) . This analysis indicated that in the pOX1 livH:: TnS plasmid, Tn5 was inserted within the 0.5-kb BglII-SalI segment about 100 base pairs (bp) downstream from the BglII site (Fig. 1) . These data indicate that the livH gene is located downstream from livK. We assumed that Tn5 inactivates livH gene expression by interrupting the structural gene, although it is also possible that the livH gene may be located further downstream from the position of the TnS insertion. In the latter case, livH gene expression would be abolished by the polar effects of the transposon (7) . To determine whether the Tn5 location identifies the structural gene for livH, we subcloned the region of plasmid pOX1 that contained the livH:: Tn5 mutation.
Cloning the livH gene. The 1.3-kb BamHI-SalI DNA fragment from pOX1 was cloned into pBR322 that had been digested with BamHI and Sall, yielding a 5.4-kb plasmid identified as pOX14 (Fig. 1) . Previous data (24) indicate that this DNA fragment should be large enough to carry the livH gene, together with the 3'-terminal portion (360 bp) of the livK gene. We also assumed that it would not contain the promoter which serves for expression of the livH gene because previous results suggested that the livH gene product was translated from a polycistronic mRNA with the transcriptional start site located proximal to the livK gene (4, 20) . We therefore cloned the livH gene within the tetracycline resistance region of pBR322, yielding pOX14, so that expression of the livH gene could be achieved from the tetracycline promoter. In parallel to the construction of pOX14, the 1.3-kb BamHI-SalI DNA fragment from pOX1 was cloned into pOX7 which had been digested with BamHI and Sall to produce the 6.6-kb pOX16 plasmid (Fig. 1) . Plasmid pOX16 carries the livH gene together with the entire livK structural gene and its regulatory sequences.
The presence of the livH gene within the 1.3-kb BamHISalI DNA fragment and the ability of plasmids pOX14 and pOX16 to express this gene were tested for by determining the ability of these plasmids to complement the livH mutation of strain AE404. When either pOX14 or pOX16 was introduced into AE404 (livH), L-leucine high-affinity transport was restored, whereas, when either plasmid was introduced into strain AE405 (iivG), complementation of transport activity was not achieved (Table 3) . These results suggest that the entire livH gene is contained in the 1.3-kb BamHI-SalI DNA fragment and is expressed by both pOX14 and pOX16.
Nucleotide sequence of the livH gene. We sequenced the 1.3-kb BamHI-SaIl DNA fragment from pOX14 mainly by using the Maxam and Gilbert sequencing procedure with minor modifications, as described previously (20, 23 (Fig. 2 ). This prediction has been supported by the construction of a livH-lacZ gene fusion that contains only the first ATG codon (position + 1) and the next nine codons of the livH gene. This fusion produced a hybrid protein with an apparent molecular weight similar to that of wild-typegalactosidase (data not shown).
The codon usage for the livH gene was highly nonrandom and reflected the abundance of the cognate tRNA species present in E. coli (data not shown). The ATA (Ile), AAT (Asn), ACA (Thr), CAA (Gln), and AGG (Arg) codons, which are used infrequently in efficiently expressed genes in E. coli, were not used more than once in the livH gene. Similar results have been reported for the codon usage for genes coding for the membrane proteins of other bacterial transport systems (8, 12, 14) .
The DNA sequence of the livH gene (924 nucleotides) encodes a protein with a mass of approximately 38,000 daltons. The LivH protein is similar to other membraneassociated transport proteins as it is a hydrophobic protein (more than 70% of its amino acid residues are nonpolar) and appears to be positively charged at neutral pH. Leucine is one of the most abundant amino acid residues in the LivH protein, as was also found for both the LS and LIV binding proteins (20) .
The NH2-terminal sequence of the LivH protein does not contain a typical signal peptide. A cleavable signal peptide, however, has not been found for most of the known inner membrane proteins such as HisP, HisQ, HisM, LacY, MalF, and MalK (8, 10, 12, 14) . It is assumed that the internal hydrophobic domains of these proteins are sufficient to insert and assemble the proteins in the cell membrane. To analyze the hydrophobic nature of the Livfl protein, we used the method described by Argos et al. (5) . The hydrophobicity profile of the LivH protein, calculated with a window of eight residues, is shown in Fig. 3 . The LivH protein was very hydrophobic with a mean hydrophobicity of about 2. This value is similar to that calculated for the HisQ protein and bacteriorhodopsin by this same method. There were nine hydrophobic segments within the protein of an average length of 20 amino acid residues or more which were likely to span the cell membrane (Fig. 3) . Alternatively, there were only a few hydrophilic regions where most of the charge was located. Interestingly, the longest hydrophilic regions, which contained most of the charged amino acids, occurred in the middle of the protein. It is possible that these segments or domains remained outside the cell membrane, and they might represent regions that could interact with the binding protein-substrate complex or with the energycoupling component to carry out the transport events.
The livK-livH intercistronic region. The intercistronic region between the livK and livIH genes was 47 bp in length and did not appear to contain promoter-like sequences (Fig. 2) . This observation, combined with previous data from genetic studies, suggests that the livH gene is part of a polycistronic mRNA that uses the livK promoter and may also include the downstream livM and livG genes. An interesting feature of the livK-livH intergenic region is the presence of a palindromic sequence of seven bases that could lead to the formation of a stable stem-loop structure in the corresponding transcript with a calculated free energy value (34) of -22 kcal/mol. An almost identical stem-loop structure has been found in the 45-bp intergenic region between the lacZ and lac Y genes (8) . This GC-rich secondary structure was very similar to a typical transcription termination site and might represent an intercistronic regulatory element (30) (see Discussion). Identification of the LivH protein. To identify the livH gene product, the 2.85-kb HindlIl-SalI DNA fragment from pOX16 was cloned into the HindIll and Sall sites of the pACYC184 vector, to give' plasmid pOX17 (Fig. 1) . We used the plasmid pACYC184 because the vector-coded proteins migrate to a different position on SDS-acrylamide gels than do the livH gene product and the ,B-lactamase that is coded for by the plasmid pBR322. The ability of pOX17 to express the livH gene was first examined by transforming pOX17 into the transport mutant strain AE404 (livH) and by measuring the high-affinity leucine transport activity of the transformed strain. Plasmid pOX17 was able to complement the transport defect in strain AE404 (livH) but not in strain AE405 (livG) ( Table 3 ).
The polypeptides encoded by the pOX17 plasmid were expressed in minicells, labeled with L-[35S]methionine, separated by SDS-polyacrylamide gel electrophoresis and visualized by fluorography (Fig. 4) . Minicells containing only the plasmid vector pACYC184 produced one predominant polypeptide with an apparent mass of 22 kilodaltons, which was identified as the chloramphenicol resistance gene product (Fig. 4) . The additional minor bands on the gel most likely resulted from stable mRNA, which survived in the minicells (21) . Minicells containing pOX17, in addition to the chloramphenicol resistance gene product, produced another predominant polypeptide of 39 kilodaltons which is the LS binding protein. A minor protein with an electrophoretic mobility similar to that of beta-lactamase was also synthesized reproducibly by pOX17 minicells but was not made by pACYC184-containing minicells (Fig. 4) . These results suggest that this minor protein (30 kilodaltons) may be the livH gene product.
Additional evidence that the 30-kilodalton protein is encoded by the livH gene was obtained by in vitro deletion mutagenesis including the livH gene contained on the pOX17 plasmid. The 0.8-kb BamHI-BgllH DNA fragment was removed by digestion of pOX17 with BamHI and BglII, followed by religation at a low DNA concentration to produce the plasmid pOX17A. Since the 0.8-kb deleted BamHI-Bg1lI DNA fragment carries portions of both the livK and livH genes, it was expected that plasmid pOX17A would be unable to complement the livH mutation and would fail to produce the LS binding protein and the LivH protein. pOX17A was not able to restore transport when introduced into strain AE404 (Table 3) . Plasmid pOX17A-encoded polypeptides were labeled with [35S]methionine in minicells and analyzed by SDS-polyacrylamide gel electrophoresis (Fig. 4) . Neither the 39-kilodalton binding protein nor the 30-kilodalton protein were made by the pOX17A plasmid, suggesting that the 30-kilodalton protein may be the livH gene product. DISCUSSION By using genetic approaches, we determined that the high-affinity branched-chain amino acid transport in E. coli requires at least two additional components, LivH and LivG, besides the periplasmic LIV and LS binding proteins (4, 24) . The location and the nucleotide sequence of the livH gene has been determined, and a candidate for the LivH protein was tentatively identified by using minicells. The livH gene is contained within a 1.3-kb BamHI-Sall fragment of plasmid pOX1, as judged by the ability of plasmids carrying this subcloned fragment to complement strains carrying a livH mutation. The location of livH was first mapped on plasmid pOX1 by TnS mutagenesis. We have isolated both livH:: TnS and livJ:: TnS insertions by using plasmid pOX1. All of the pOX1 livJ::TnS plasmid derivatives had a functional livH gene despite the known polar effects of the transposon insertions (7). On the other hand, we found that the livH:: Tn5 insertion exerted a polar effect on livG, since the plasmid pOXllivH:: TnS was not able to complement the transport defect of strain AE405 (livG) ( Table 2) . These results are in agreement with other findings from this laboratory, and they suggest the existence of at least two transcriptional units for the liv locus, one for the livJ gene and another for the livK, livH, livM, and livG genes (20, 24) .
The nucleotide sequence of the 1. , personal communication) . Similarly, a comparison of the amnino acid sequences determined for the Liv and His periplasmic binding proteins has shown only marginally significant homologies, although the X-ray structures of several binding proteins show a common bilobate conformation (19) . On the other hand, an amino acid sequence comparison between HisP and MalK proteins, the probable energy-coupling components of their transport systems, shows a significant homology (11, 15, 16) . Also, an extensive comparison of the amino acid sequences of the MalF protein, a membrane component of the maltose transport system, with the membrane components of the histidine transport system (HisP, HisQ, and HisM) of S. typhimurium, as well as to other inner membrane nontransport proteins, showed, again, no significant homology (10) . It has been hypothesized that all periplasmic transport systems may have originated from a common ancestor system (18) . If this hypothesis is correct, it appears that the transmembrane transport proteins of the various systems have retained their hydrophobic natures rather than specific amino acid sequences.
The identification of the livH gene product has been difficult, most likely due to the poor expression of the gene. The low level of expression of the membrane transport components appears to be a common property of all presently characterized osmotic shock-sensitive transport systems (2, 6, 33) . The LivH protein has been tentatively identified in minicells as a weak protein band corresponding to a mass of 30 kilodaltons on the basis of the expression of this protein from plasmid pOX17 (livH+), but not from the vector pACYC184 or from the plasmid pOX17A (livH-). The mobility of the protein is similar to that of the beta-lactamase protein, and preliminary cellular fractionation experiments with minicells have indicated that it is a membraneassociated protein (data not shown). The apparent mass of the putative LivH protein as observed from the electrophoretic mobility of the protein on SDS gels (30 kilodaltons) is smaller than that predicted from the nucleotide sequence (38 kilodaltons). Such discrepancies appear to be common for hydrophobic proteins, presumably due to an abnormally high capacity for binding SDS (8, 10) .
The molecular mechanism responsible for the decreased expression of the membrane proteins still remains obscure. In the case of LivH, it is possible to hypothesize that the potential stem-loop structure in the livK-livH intergenic region may decrease the level of the mRNA coding for the membrane components either as a transcriptional attenuator or as a recognition site for mRNA processing. Alternatively, since the distance between the potential stem-loop and the potential ribosome binding site is only 7 bp, it is also possible that this structure may reduce ribosome binding and, thereby, alter or inhibit translational initiation. We have recently constructed livH-lacZ fusions which contain only the first 10 amino acids of the LivH protein fused in frame to ,-galactosidase, and we observed that the livH-lacZ hybrid gene is efficiently expressed. These preliminary results could be taken to suggest that a more complex posttranscriptional regulatory mechanism may be involved in the expression of the livH gene.
